Decision Support Unit |
8 — th Floor, 259 Queen St, Brisbane — 3 — rd Floor Blackburn House, 199 Grenfell St, Adelaide
Intranet site: http://intranet/nat/comp/dp/Nop/dsu/dsudefault.htm
08 April 2005
THE FOLLOWING RMA SOPS WILL TAKE EFFECT ON 13 APRIL 2005
Dermatomyositis |
|
|
Gastro-oesophageal reflux disease Sleep apnoea |
|
Nil |
IMPORTANT OPERATIONAL FEATURES
Gastro-oesophageal reflux disease |
Revocation – 11 & 12 of '05 Replaces 52 and 53 of '02 |
- The definition has been slightly changed to specify that the condition must be chronic. In the medical context “chronic” means persisting over a long period of time (and it has no meaning with regard to severity).
- The minimum smoking factor requirements have been changed from 5/day + 1 pk yr (RH) and 10/day + 2 pk yrs (BOP) to 10/day for 6 months (RH) and 20/day for 6 months (BOP).
- The alcohol factor, previously requiring dependence or abuse, has been changed to a dose of alcohol.
- Treatment with a nonsteroidal anti-inflammatory drug, previously a factor for onset and worsening in both RH and BOP SOPs, is now just a worsening factor in the RH SOP only.
- Undergoing a gastrectomy, previously covered by the surgical procedure factor, is now included as a factor on its own.
- There are new factors for:
- Sjögren's syndrome (RH & BOP);
- eradication of Helicobacter pylori in a person with chronic gastritis (RH only);
- doxycycline (RH worsening only); and
- a drug causing acute erosive oesophagitis (RH worsening only).
Sleep apnoea |
Revocation – 13 & 14 of '05 Replaces 39 and 40 of '97 |
- As before, the SOP does not cover isolated sleep apnoea without clinical consequences. Brief and infrequent cessation of breathing (apnoea) during sleep is normal and not a disease.
- In the previous SOP there was a definition note that excluded temporary sleep apnoea due to alcohol consumption. That note has been removed, and alcohol-related sleep apnoea is now covered by the SOP, but note that alcohol is included as a worsening factor only.
- There are new causal and worsening factors in both RH and BOP SOPs for end-stage renal failure.
- Changes to other factors are cosmetic only.
Dermatomyositis |
- This SOP covers a rare disorder involving progressive muscle weakness and skin changes. Claims will be very infrequent. There are causal factors in the RH SOP only, for being treated with certain drugs.
Contact Officers for this bulletin: |
|
Dr Bev Grehan — x 48376 Dr Jon Kelley — x 48412 |
B91newsopsApr05.doc — Page 1 of 2
Decision Support Unit
Business Development, Monitoring and Support Section
Disability Compensation Branch
Australian Government Department of Veterans' Affairs